Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology

Journal Scan / Research · February 20, 2014

Mesothelin Is a Marker of Tumor Aggressiveness in Lung Adenocarcinoma

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Clinical Cancer Research
Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated With Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Clin. Cancer Res 2014 Jan 27;[EPub Ahead of Print], SS Kachala, AJ Bograd, J Villena-Vargas, K Suzuki, EL Servais, K Kadota, J Chou, CS Sima, E Vertes, VW Rusch, WD Travis, M Sadelain, PS Adusumilli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated